About: Recommendations on the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Recommendations on the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Recommendations on the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19
Creator	Goodman, Karyn Hawkins, Maria Hosni, Ali Scorsetti, Marta Tchelebi, Leila Dawson, Laura Dawson, M Haustermans, Karin Haustermans, L Hawkins, F Hosni, M Huguet, Florence Scorsetti, K
source	Elsevier; Medline; PMC; WHO
abstract	Abstract As of April 6, 2020, there are over 1,200,000 reported cases and 70,000 deaths worldwide due to COVID-19, the disease caused by the SARS-CoV-2 virus, and these numbers rise exponentially by the day.[1] According to the Centers for Disease Control (CDC), the most effective means of minimizing the spread of the virus is through reducing interactions between individuals.[2] We performed a review of the literature, as well as national and international treatment guidelines, seeking data in support of the RADS principle (Remote visits, Avoid radiation, Defer radiation, Shorten radiation)[3] as it applies to gastrointestinal cancers. The purpose of the present work is to guide radiation oncologists managing patients with gastrointestinal cancers during the COVID-19 crisis in order to maintain the safety of our patients, while minimizing the impact of the pandemic on cancer outcomes.
has issue date	2020-04-13(xsd:dateTime)
bibo:doi	10.1016/j.radonc.2020.04.010
bibo:pmid	32342878
has license	els-covid
sha1sum (hex)	6bacdb5a14a36c805b63079c903b660d1fb55934
schema:url	https://doi.org/10.1016/j.radonc.2020.04.010
resource representing a document's title	Recommendations on the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19
has PubMed Central identifier	PMC7194719
has PubMed identifier	32342878
schema:publication	Radiother Oncol
resource representing a document's body	covid:6bacdb5a14a36c805b63079c903b660d1fb55934#body_text
is schema:about of	named entity 'Journal' named entity 'USE OF' named entity 'doi' named entity 'Oncology' named entity 'COVID-19' named entity 'radiation therapy' named entity 'COVID-19' named entity 'doi' named entity 'Neoadjuvant chemotherapy' named entity 'gemcitabine' named entity 'adjuvant' named entity 'rate of death' named entity 'coronavirus' named entity 'radiation therapy' named entity 'stenting' named entity 'carboplatin' named entity 'chemoradiation' named entity '5-fluorouracil' named entity 'performance status' named entity 'CALGB' named entity 'anal cancer' named entity 'risk stratification' named entity 'radiation treatment' named entity 'COVID' named entity 'leucovorin' named entity 'cancer center' named entity 'COVID' named entity 'esophageal cancer' named entity 'radiotherapy' named entity 'global pandemic' named entity 'adjuvant radiation therapy' named entity 'tumor' named entity 'SBRT' named entity 'toxicity' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'chemotherapy regimen' named entity 'level 1' named entity 'patient safety' named entity 'paclitaxel' named entity 'paclitaxel' named entity 'fractionation' named entity 'virus' named entity 'dose of radiation' named entity 'cisplatin' named entity 'National Institute for Health and Care Excellence' named entity 'mitomycin-C' named entity 'SARS-CoV-2 virus' named entity 'quarantine' named entity 'histology' named entity 'SBRT' named entity 'Oligo' named entity 'Induction chemotherapy' named entity 'COVID-19' named entity 'neoadjuvant' named entity 'Radiation therapy' named entity 'complete response' named entity 'radiation therapy' named entity 'neoadjuvant chemotherapy' named entity 'PET' named entity 'COVID-19 pandemic' named entity 'induction chemotherapy' named entity 'RTOG' named entity 'virus' named entity 'CDC' named entity 'stay home' named entity 'cholangiocarcinoma' named entity 'adjuvant' named entity 'radiation therapy'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software